Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jun 2009 for Ernexa Therapeutics Inc., €3,370.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +2.2%Entry US$337,500.00 · Close at T+365 US$345,000.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nicholas A. Glassman: trading record in brief
Only one filing by Nicholas A. Glassman is known so far (22 June 2009): an open-market purchase, €3,370, in Ernexa Therapeutics Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nicholas A. Glassman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 10,000 shares@ US$0.47Common StockSEC:0001019687-09-002228:0Canonical exit: 16 Sept 2009 (T+90)
1 of 1 declaration
